Key result
Noninvasive tests of vascular function, such as flow-mediated vasodilation and brachial-ankle pulse wave velocity, provide valuable information for cardiovascular risk stratification and pathophysiology.
Why the study?
Noninvasive tests of vascular function provide valuable information for cardiovascular risk management, prompting a summary of emerging evidence published in 2023-2024.
Answers are grounded in this paper and cite their sources.
This review highlights recent advancements in noninvasive vascular function testing for cardiovascular risk stratification and understanding the pathophysiology of cardiometabolic disorders.
Noninvasive tests of vascular function are useful for assessing the severity of atherosclerosis and risk of cardiovascular events, understanding the pathophysiology of cardiometabolic disorders, and investigating the effects of therapeutic interventions on cardiovascular morbidity and mortality, all of which can provide additional information for the management of patients with cardiovascular risk factors or a history of cardiovascular disease. In 2023-2024, many excellent articles on vascular function were published in Hypertension Research and other major cardiovascular and hypertension journals, and we summarize the emerging evidence on vascular function in this review. We hope that this review will be helpful for the management of patients with cardiovascular risk factors in clinical practice and for future basic and clinical research on vascular function.
No takes yet. Share an insight, caveat, or question.
Maruhashi et al. (2024) conducted a review in Hypertension and cardiovascular risk factors. Vascular function tests (FMD, baPWV, CAVI, PVR) was evaluated. Noninvasive tests of vascular function, such as flow-mediated vasodilation and brachial-ankle pulse wave velocity, provide valuable information for cardiovascular risk stratification and pathophysiology.
Synapse has enriched 10 related papers. Consider them for comparative context: